A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635 EA Forster, IA Cliffe, DJ Bill, GM Dover, D Jones, Y Reilly, A Fletcher European journal of pharmacology 281 (1), 81-88, 1995 | 667 | 1995 |
Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist A Fletcher, EA Forster, DJ Bill, G Brown, IA Cliffe, JE Hartley, DE Jones, ... Behavioural brain research 73 (1-2), 337-353, 1995 | 598 | 1995 |
Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H] WAY-100635 and [11C] way-100635 H Hall, C Lundkvist, C Halldin, L Farde, VW Pike, JA McCarron, A Fletcher, ... Brain research 745 (1-2), 96-108, 1997 | 326 | 1997 |
Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents A Fletcher, IA Cliffe, CT Dourish Trends in Pharmacological Sciences 14 (12), 441-448, 1993 | 274 | 1993 |
WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors A Fletcher, DJ Bill, SJ Bill, IA Cliffe, GM Dover, EA Forster, JT Haskins, ... European journal of pharmacology 237 (2-3), 283-291, 1993 | 266 | 1993 |
Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11C] WAY-100635 VW Pike, JA McCarron, AA Lammertsma, S Osman, SP Hume, ... European journal of pharmacology 301 (1-3), R5-R7, 1996 | 262 | 1996 |
A pharmacological profile of WAY-100635, a potent and selective 5-HT1A receptor antagonist A Fletcher, DJ Bill, IA Cliffe, EA Forster, D Jones, Y Reilly British Journal of Pharmacology-Proceedings Supplement 112, 91P, 1994 | 137 | 1994 |
First delineation of 5-HT1A receptors in human brain with PET and [11C] WAY-100635 VW Pike, JA McCarron, AA Lammerstma, SP Hume, K Poole, PM Grasby, ... European journal of pharmacology 283 (1-3), R1-R3, 1995 | 136 | 1995 |
Discovery of nonxanthine adenosine A2A receptor antagonists for the treatment of Parkinson’s disease SM Weiss, K Benwell, IA Cliffe, RJ Gillespie, AR Knight, J Lerpiniere, ... Neurology 61 (11_suppl_6), S101-S106, 2003 | 108 | 2003 |
Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand,[O-methl-11C] WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of … S Osman, C Lundkvist, VW Pike, C Halldin, JA McCarron, CG Swahn, ... Nuclear medicine and biology 23 (5), 627-634, 1996 | 106 | 1996 |
(S)-N-tert-Butyl-3-(4-(2-methoxyphenyl) piperazin-1-yl)-2-phenylpropanamide [(S)-WAY-100135]: a selective antagonist at presynaptic and postsynaptic 5-HT1A receptors IA Cliffe, CI Brightwell, A Fletcher, EA Forster, HL Mansell, Y Reilly, ... Journal of medicinal chemistry 36 (10), 1509-1510, 1993 | 104 | 1993 |
Antagonists of the human adenosine A2A receptor. Part 3: Design and synthesis of pyrazolo [3, 4-d] pyrimidines, pyrrolo [2, 3-d] pyrimidines and 6-arylpurines RJ Gillespie, IA Cliffe, CE Dawson, CT Dourish, S Gaur, AM Jordan, ... Bioorganic & medicinal chemistry letters 18 (9), 2924-2929, 2008 | 84 | 2008 |
PRE-CLINICAL DEVELOPMENT OF A RADIOLIGAND FOR STUDIES OF CENTRAL 5-HT1A RECEPTORS IN VIVO-(11C) WAY-100635 VW Pike, JA McCarron, SP Hume, S Ashworth, J Opacka-Juffry, S Osman, ... Medicinal Chemistry Research 5 (2), 208-227, 1995 | 84 | 1995 |
Evaluation of [O-methyl-3H] WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brain SP Hume, S Ashworth, J Opacka-Juffry, RG Ahier, AA Lammertsma, ... European journal of pharmacology 271 (2-3), 515-523, 1994 | 79 | 1994 |
N-((phenyl, benzodioxinyl or N-heteroarylpiperazinyl) alkyl)-N-(N-heteroaryl) substituted carboxamides IA Cliffe, HL Mansell US Patent 6,127,357, 2000 | 78 | 2000 |
Tertiary alkyl functionalized piperazine derivatives MA Abou-Gharbia, JP Yardley, IA Cliffe US Patent 4,988,814, 1991 | 74 | 1991 |
A retrospect on the discovery of WAY-100635 and the prospect for improved 5-HT1A receptor PET radioligands IA Cliffe Nuclear medicine and biology 27 (5), 441-447, 2000 | 60 | 2000 |
Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno [3, 2-d] pyrimidine-4-methanone derivatives RJ Gillespie, DR Adams, D Bebbington, K Benwell, IA Cliffe, CE Dawson, ... Bioorganic & medicinal chemistry letters 18 (9), 2916-2919, 2008 | 54 | 2008 |
Synthesis and in vitro activity of novel 1, 2, 4-triazolo [4, 3-a] pyrimidine oxazolidinone antibacterial agents MK Khera, IA Cliffe, T Mathur, O Prakash Bioorganic & medicinal chemistry letters 21 (10), 2887-2889, 2011 | 48 | 2011 |
Indoline derivatives as 5-HT2C receptor agonists JM Bentley, DR Adams, D Bebbington, KR Benwell, MJ Bickerdike, ... Bioorganic & medicinal chemistry letters 14 (9), 2367-2370, 2004 | 47 | 2004 |